In 2002, Benicar was approved by the FDA for the treatment of hypertension or high blood pressure .. From 2002 to 2008, pharmaceutical maker Daiichi Sankyo spent close to$1 billion promoting the product and making claims that their drug was safe and more effective than other hypertensive drugs on the market. The use of this drug has now been linked to severe intestinal problems, chronic diarrhea, and a severe condition known as sprue-like enteropathy.

THE YANKOWITZ LAW FIRMis currently investigating Benicar claims. If you or someone you love has been diagnosed with sprue-like enteropathy or other severe gastrointestinal problems after taking Benicar, call us at 1-800-LAW-3333 immediately As always, we will evaluate your potential case for FREE.


IN 2012, The U.S. Food and Drug Administration recently warned consumers that the use of Benicar could cause severe gastrointestinal problems, including:

  • Sprue-like enteropathy
  • Villous Atrophy
  • Malnourishment
  • Dehydration
  • Chronic diarrhea
  • Malnutrition
  • Nausea
  • Vomiting
  • Abdominal pain
  • Weight loss
  • And more


The most serious gastrointestinal complication experienced by patients taking Benicar is sprue-like enteropathy. This severe GI disorder can cause serious symptoms, such as severe, chronic diarrhea, substantial weight loss, and malnutrition. To make matters worse, this condition may take years to develop and be diagnosed and is often mistaken for Celiac disease or gluten intolerance. By the time sprue-like enteropathy is diagnosed, patients are sick, malnourished, and often hospitalized.

Benicar has been marketed as Benicar, Benicar HCT, Azor, Tribenzor, and the generic name olmesartan medoxomil. In 2012, researchers from the Mayo Clinic uncovered the link between Benicar and sprue-like enteropathy. Months later, scientists at the AmericanCollege of Gastroenterology found that the active ingredient in Benicar, olmesartan, was also linked to sprue-like enteropathy and debilitating GI symptoms in over 40 patients. In 2013, the FDA required Daiichi Sankyo to update their labels to reflect these findings and warned the public of Benicar’s dangers.


In 2014, Benicar lawsuits began to be filed citing failure to warn and other negligence by Daiichi Sankyo. The first lawsuit was filed on behalf of a patient who was forced to spend 100 days hospitalized because of his GI issues. He suffered cataracts, compression fractures, and severe malnutrition and must now be fed through a feeding tube. His lawsuit alleges that the company continued to put consumers at risk by not adequately warning of the dangers associated with using their drug. It also alleges that Daiichi Sankyo failed to adequately test their product before introducing it to the public.


If you or someone you love has been diagnosed with sprue-like enteropathy or experienced severe gastrointestinal complications after taking Benicar contact THE YANKOWITZ LAW FIRM @ 1-800-LAW-3333 Drug companies who routinely put profits before people should pay for their negligence aw well as their unscrupulous behavior. To learn more about your legal options or to schedule a FREE CONSULTATIONcall the NATIONAL PRODUCT LIABILITY LAWYERS at THE YANKOWITZ LAW FIRMtoday at 1-800-LAW-3333 or fill out our confidential Contact Form.